tiprankstipranks
Advertisement
Advertisement

Cannabix Marijuana Breath Test Lands Cover Spot in AlcoPro’s 2026 Catalogue

Story Highlights
  • Cannabix’s Marijuana Breath Test will feature on AlcoPro’s 2026 catalog cover, reaching over 85,000 businesses.
  • The AlcoPro and Omega partnerships boost Cannabix’s visibility and credibility in advanced workplace drug testing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cannabix Marijuana Breath Test Lands Cover Spot in AlcoPro’s 2026 Catalogue

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Cannabix Technologies ( (TSE:BLO) ).

Cannabix Technologies’ Marijuana Breath Test (MBT) has been selected to appear on the cover of AlcoPro Inc.’s 2026 product catalogue, which is distributed to more than 85,000 businesses in the U.S. and abroad, including law enforcement and corrections clients. The feature underscores Cannabix’s growing partnership with AlcoPro in pre-launch marketing of the MBT in the U.S. and highlights the company’s integration of proprietary breath collection technology with LC-MS analysis through its collaboration with Omega Laboratories, positioning Cannabix to gain greater visibility and credibility in the professional drug-testing market as employers seek more accurate and non-invasive tools to address evolving workplace safety and impairment challenges.

The most recent analyst rating on (TSE:BLO) stock is a Hold with a C$0.62 price target. To see the full list of analyst forecasts on Cannabix Technologies stock, see the TSE:BLO Stock Forecast page.

Spark’s Take on TSE:BLO Stock

According to Spark, TipRanks’ AI Analyst, TSE:BLO is a Neutral.

The score is primarily held down by very weak financial performance (minimal revenue, large losses, and ongoing cash burn) despite low leverage. Technical indicators are modestly supportive in the near term, but valuation is constrained by negative earnings and no dividend data.

To see Spark’s full report on TSE:BLO stock, click here.

More about Cannabix Technologies

Cannabix Technologies Inc. is a Canadian developer of marijuana and alcohol breathalyzer technologies aimed at law enforcement, workplaces and laboratories. The company focuses on screening devices for delta-9 THC, the primary psychoactive component of cannabis, and alcohol, including its Breath Logix series of breath alcohol detection devices designed for employer and other professional settings.

Average Trading Volume: 37,580

Technical Sentiment Signal: Buy

Current Market Cap: C$76.28M

Find detailed analytics on BLO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1